Medtronic, Inc. Share Price Nyse
Equities
US5850551061
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
09/05 | Arecor Therapeutics collaborates with Medtronic on novel insulin | AN |
09/05 | Arecor Therapeutics, Medtronic Team Up for Thermostable Insulin Development | MT |
Sales 2024 * | 32.24B 2,691B | Sales 2025 * | 33.57B 2,803B | Capitalization | 110B 9,184B |
---|---|---|---|---|---|
Net income 2024 * | 4.56B 381B | Net income 2025 * | 5.24B 438B | EV / Sales 2024 * | 4.1 x |
Net Debt 2024 * | 22.21B 1,854B | Net Debt 2025 * | 21.12B 1,763B | EV / Sales 2025 * | 3.91 x |
P/E ratio 2024 * |
23.6
x | P/E ratio 2025 * |
20.5
x | Employees | - |
Yield 2024 * |
3.32% | Yield 2025 * |
3.49% | Free-Float | 99.81% |
Latest transcript on Medtronic, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Geoffrey Martha
CEO | Chief Executive Officer | 54 | 26/15/26 |
Karen Parkhill
DFI | Director of Finance/CFO | 58 | 01/16/01 |
Gregory Smith
COO | Chief Operating Officer | 63 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Donnelly
BRD | Director/Board Member | 62 | 01/13/01 |
Kendall Powell
BRD | Director/Board Member | 70 | 01/07/01 |
Randall Hogan
BRD | Director/Board Member | 68 | 01/15/01 |
1st Jan change | Capi. | |
---|---|---|
-4.84% | 182B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+24.51% | 32.3B | |
+3.43% | 26.53B | |
-0.32% | 24.96B | |
+13.67% | 25.02B |